ANTIMICROBIAL RESISTANCE (AMR)

NEW: Preliminary 2019 AGENDA FOR
Antimicrobial Resistance (AMR)

 

DESCRIPTION

The focus of this 3-day workshop is on understanding the complex causes underlying the emergence and spread of AMR, and on practical approaches to tackle antibiotic misuse in different settings.

 

Course Directors

Makeda Semret, MSc, MD, FRCPC

Lead, Antimicrobial Stewardship Program, McGill University Health Centre

Director, Training Program in Infectious Diseases and Medical Microbiology, McGill University

Erika Vlieghe MD
Head of the department of General Internal Medicine, Infectious diseases and Tropical Medicine, University Hospital Antwerp
Professor of infectious diseases, University of Antwerp

 

Course Faculty

Emmanuel Bottieau, MD – Institute of Tropical Medicine, Antwerp, Belgium
Peter J. Dailey, PhD, MPH – University of California, Berkeley
Bersabel Ephrem, MPA – Director General, Centre for Communicable Diseases and Infection Control, Public Health Agency, Canada
Coralith Garcia, MD – Universidad Peruana Cayetano, Peru
Haileyesus Getahun, MD PhD MPH – WHO, Geneva
David Goldfarb, MD FRCP – University of British Columbia, Canada
Louis-Patrick Haraoui, MD MSc, FRCP(C) – Université de Sherbrooke
Eili Klein, MA, PhD – Johns Hopkins University and Center For Disease Dynamics, Economics & Policy
Christian Lavallée, MD, FRCP(C) – Université de Montréal
Yves Longtin, MD FRCP(C) – McGill University
Mark Miller, MD MSc FRCP(C) – bioMérieux
Yoshiko Nakamachi, RN, BScN, BA, PMP – University Health Network, Toronto
Dilip Nathwani, MD (pre-recorded lecture) – University of Dundee, Scotland
Piero Olliaro, MD, PhD – FIND
Jennifer Osborne, FINDDx, Seattle, USA
Madhu Pai, MD PhD – McGill University, Canada
Jeff Pernica, MD FRCP – McMaster University, Canada
Louis Valiquette, MD MSc FRCP(C) – Université de Sherbrooke
Jorg Janne Vehreschild, MD – University of Cologne
Heiman Wertheim, MD PhD, Radboud University, Netherlands
Cédric Yansouni, MD, FRCPC, DTM&H – McGill University

 

Additional Panelists

Timur Abdullaev – Lawyer and patient advocate, Uzbekistan
Jane Carter, MD – AMREF, Kenya
Gebremedhin B. Gebretekle, MPharm – Addis Ababa University, Ethiopia
Micheal Libman, MD FRCP – McGill University, Canada
Tien Nguyen, MD FRCP – McGill University, Canada
Tevor Peter, PhD, MPH – Clinton Health Access Initiative (CHAI) and Chair of the African Society for Laboratory Medicine, Bostwana
Semaria Solomon, PhD – St Paul’s Medical College, Ethiopia
Wondewosen Tsegaye, PhD – St Paul’s Medical College, Ethiopia

 

Content

Antimicrobial resistance (AMR) is now one the biggest threats facing modern medicine. Initially described mostly in association with hospital-associated infections in high-income countries, the highest rates of AMR are now reported from low and middle-income countries (LMIC) around the world. The causes underlying the global rise in AMR are complex, but central to this crisis is overconsumption of antibiotics.

 

This 3-day workshop will focus on understanding the complex causes underlying the emergence and spread of AMR, and on approaches to tackle antibiotic misuse in different settings. The workshop format is a mix of plenary talks and panel discussions, with opportunities to interact with participants who work across the spectrum of the antimicrobial resistance space in different countries.

Clinicians, researchers, implementers, and health educators from both high-income and LMIC will share questions, successes, and lessons learned to advance the field of AMR.

 

NOTE: Global Health Diagnostics and the Antimicrobial Resistance course will be taught together on Wednesday, June 12th.

 

TARGET AUDIENCE

This course appeals to a wide range of participants including:

  • Clinicians, pharmacists, technologists, researchers and students studying infectious diseases, tropical medicine, or global health
  • Policy makers and public health agency officials
  • Product developers and funders
  • Community advocacy groups working in global health

 

ENROLMENT

Maximum of 100 participants.